The white paper recommends extending endoscopic classification of gastroesophageal junction integrity beyond the slope.

Published Date: 08 Mar 2023

A new white paper from the American Foregut Society expands gastrointestinal tract (EGJ) classification, including axial hiatal hernia length, hiatal hernia opening diameter, ...

Read Full News

Latest News

Blood Test Could Spot Gut Damage in Celiac Disease

A distinctive pattern of inflammatory proteins in the blood of adults with celiac disease reflects the severity of gut damage and may offer a noninvasive way to monitor disease activity.

Ustekinumab Biosimilar Switch Maintains Outcomes in Crohn's

Patients with Crohn's disease in remission who switch from reference ustekinumab to biosimilar versions maintain similar clinical success rates over 6 months to those continuing reference treatment.

Adding Radiotherapy to NAC Shows No Survival Benefit in PDAC

For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.

Real-World Data Favor Upadacitinib in Bio-Exposed UC

A Portuguese real-world study finds that upadacitinib outperforms tofacitinib and ustekinumab — top-tier options after UC treatment failure — with higher remission rates at 16 and 52 weeks.

FDA Okays RAS Inhibitor Daraxonrasib for Pancreatic Cancer

Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients.

FDA Approves Zanidatamab Regimen for HER2-Positive GEA

Zanidatamab with tislelizumab and chemotherapy leads to overall survival of 26.4 months.

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Latest News

A distinctive pattern of inflammatory proteins in the blood of adults with celiac disease reflects the severity of gut damage and may offer a noninvasive way to monitor disease activity.

Patients with Crohn's disease in remission who switch from reference ustekinumab to biosimilar versions maintain similar clinical success rates over 6 months to those continuing reference treatment.

For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.

A Portuguese real-world study finds that upadacitinib outperforms tofacitinib and ustekinumab — top-tier options after UC treatment failure — with higher remission rates at 16 and 52 weeks.

Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients.

Zanidatamab with tislelizumab and chemotherapy leads to overall survival of 26.4 months.

News All Time

One Surgical Approach May Be Better for Complex Gallbladder Disease

Robotic cholecystectomy tied to reduced adverse outcomes over laparoscopic approach

You've Heard of Cyclospora. What Other Parasites Can You Catch From Food?

Experts describe some of the most common protozoa and worms

Iceberg Blamed in Diarrhea Outbreak; Masking Urged in Cities; DEA's Ketamine Probes

Health news and commentary gathered by MedPage Today staff

What's the Best Way to Test for Cyclospora Infection?

Microscopy and DNA tests are both viable, but sensitivity, cost, and availability vary

930 Dead in Outbreak; FDA Backtracks on Iceberg Lettuce; Chronic Cough Drug Fizzles

Health news and commentary gathered by MedPage Today staff

Novel Drug Shows Promise in Crohn's, Ulcerative Colitis

Duvakitug may be suitable for patients previously treated with advanced therapy

Inside the Intestinal Crypt: Untold Stories of Cyclospora

There's still much to learn about the parasite's past, present, and future

Lettuce Supplier Still the Focus in Cyclospora Outbreak, Despite Faulty Test Result

FDA says its investigation and outbreak data continue to point to Taylor Farms' iceberg lettuce

Singing for Chronic Belching; Excess Cancers in Crohn's; Dual Agonist for Liver Fat

News and commentary from the world of gastroenterology and hepatology

FDA Approves New Blood Test for Colon Cancer Screening

SimpleScreen CRC is indicated for adults 45 and up at average risk

Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead

Food safety leaders across the U.S. are raising alarms over federal cuts

Intensified Pre-Op Chemoradiotherapy Fails in Locally Advanced Rectal Cancer

DFS at 3 years nearly identical with the addition of irinotecan, but with more toxicity

Diabetes and Pancreas Cancer; Crohn's Tied to Joint Infections; Hypnotherapy for IBS

News and commentary from the world of gastroenterology and hepatology

Michigan Reports First Two U.S. Deaths Related to Diarrhea-Causing Parasite

The CDC says cyclosporiasis is rarely deadly

FIT-Based Screening Linked to Drop in Colorectal Cancer Mortality

Inflection point occurred around 2012, 3 years after screening program was implemented

Study Examines Link Between IBD and Psychiatric Disorders

Does psychiatric morbidity precede IBD onset or arise after diagnosis?

Recommended News For You

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers explore e-bikes for cancer recovery

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Recommended Articles For You

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target 

What is Red Cell Distribution Width and Why Should You Care? 

Hematopoietic Resilience and Future Clinical Performance: Mechanisms, Clinical Implications, and Emerging Perspectives 

Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survey: Record Numbers of US Adults Report Depression.

2.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

5.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

1.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

2.

Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy

3.

Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial

4.

Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes

5.

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Thromboprophylaxis In Medical Settings- An Update

2.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

3.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Clinical Insights in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot